|
J Biol Chem, Vol. 274, Issue 31, 21679-21687, July 30, 1999
DNA Ligase III Is Recruited to DNA Strand Breaks by a Zinc Finger
Motif Homologous to That of Poly(ADP-ribose) Polymerase
IDENTIFICATION OF TWO FUNCTIONALLY DISTINCT DNA BINDING REGIONS
WITHIN DNA LIGASE III*
Zachary B.
Mackey §,
Claude
Niedergang¶,
Josiane
Ménissier-de
Murcia¶,
John
Leppard ,
Karin
Au ,
Jingwen
Chen ,
Gilbert
de Murcia¶, and
Alan E.
Tomkinson **
From the Department of Molecular Medicine, Institute
of Biotechnology, The University of Texas Health Science Center at San
Antonio, San Antonio, Texas 78245, ¶ UPR 9003 du Centre National
de la Recherche Scientifique, Laboratoire Conventionné avec le
Commissariat à l'Energie Atomique, Ecole Supérieure de
Biotechnologie de Strasbourg, Boulevard Sébastien Brant, F-67400
Illkirch-Graffenstaden, France, and Department of Molecular
Genetics, Glaxo Wellcome Inc.,
Research Triangle Park, North Carolina 27709
 |
ABSTRACT |
Mammalian DNA ligases are composed of a conserved
catalytic domain flanked by unrelated sequences. At the C-terminal end
of the catalytic domain, there is a 16-amino acid sequence, known as
the conserved peptide, whose role in the ligation reaction is unknown.
Here we show that conserved positively charged residues at the
C-terminal end of this motif are required for enzyme-AMP formation.
These residues probably interact with the triphosphate tail of ATP,
positioning it for nucleophilic attack by the active site lysine. Amino
acid residues within the sequence RFPR, which is invariant in the
conserved peptide of mammalian DNA ligases, play critical roles in the
subsequent nucleotidyl transfer reaction that produces the
DNA-adenylate intermediate. DNA binding by the N-terminal zinc finger
of DNA ligase III, which is homologous with the two zinc fingers of
poly(ADP-ribose) polymerase, is not required for DNA ligase activity
in vitro or in vivo. However, this zinc finger
enables DNA ligase III to interact with and ligate nicked DNA at
physiological salt concentrations. We suggest that in vivo
the DNA ligase III zinc finger may displace poly(ADP-ribose) polymerase
from DNA strand breaks, allowing repair to occur.
 |
INTRODUCTION |
Three human genes encoding DNA ligases, LIG1,
LIG3, and LIG4, have been isolated (1, 2). The
enzymes encoded by these genes and all other eukaryotic DNA ligases
utilize ATP as a co-factor in the DNA joining reaction. In this regard,
eukaryotic DNA ligases are similar to the DNA ligases encoded by the
bacteriophages T4 and T7. The formation of a covalent enzyme-NMP
reaction intermediate, in which the NMP moiety is linked to a lysine
residue via a phosphoramidite bond, is a property shared by DNA
ligases, RNA ligases, and mRNA capping enzymes (3). In DNA ligases,
the active site lysine was first identified in bovine DNA ligase I (4).
By comparing the amino acid sequence of the adenylated peptide from
bovine DNA ligase I with other DNA ligases, an active site motif,
KXDGXR, that is diagnostic for DNA ligases
was defined (4).
A second peptide sequence, known as the conserved peptide, was
initially revealed by a comparison of vaccinia DNA ligase with the DNA
ligases encoded by the CDC9 and CDC17 genes of
Saccharomyces cerevisiae and Schizosaccharomyces
pombe, respectively (5). Subsequently, sequences exhibiting
homology with the conserved peptide have been detected in all
eukaryotic and pox virus DNA ligases (1, 2) except for the putative DNA
ligase encoded by African swine fever virus (6). At the present time,
the role of the conserved peptide in the DNA joining reaction is not known. Since the sequences and the number of amino acids between the
active site and conserved peptide motif are similar in all eukaryotic
DNA ligases, it appears that the conserved motifs define a minimal
catalytic domain (1, 2, 7). The generation of catalytically active
fragments of mammalian DNA ligase I containing the conserved motifs by
limited proteolysis (8) and the complementation of the conditional
lethal phenotype of a yeast cdc9 DNA ligase mutant by
fragments of human DNA ligase I cDNA that encode the putative
catalytic domain (9) support this notion.
Alignment of DNA ligases, mRNA capping enzymes, and RNA ligases led
to the identification of another four conserved motifs in addition to
the active site and conserved peptide (3). In the crystal structure of
T7 DNA ligase, the active site lysine residue is at the bottom of a
cleft between two domains (10). All of the other motifs, except for the
conserved peptide, form the protein surfaces that surround the active
site lysine residue (10). Thus, it seems likely that this structural
organization occurs in all the enzymes that form a covalent enzyme-NMP
reaction intermediate.
Considerably less is known about how DNA ligase interacts with nicked
DNA in the latter steps of the ligation reaction. Although the
catalytic domain must contain amino acid residues that recognize and
interact with nicks in duplex DNA, the molecular mechanisms by which
the AMP moiety is transferred to the 5'-phosphate terminus at a nick in
duplex DNA and by which the phosphodiester bond is then formed from the
DNA-adenylate intermediate have not been defined. Interestingly, DNA
ligase III and DNA ligase III , which are generated by alternative
splicing of the mammalian LIG3 gene transcript, have an
amino-terminal sequence that is homologous with the zinc fingers of
poly(ADP-ribose) polymerase
(PARP)1 that interact with
DNA strand breaks (7, 11, 12). This has led to the suggestion that the
zinc finger of DNA ligase III may function as the nick sensor for this
enzyme (13).
In this study, we demonstrate that the DNA ligase III zinc finger does
indeed bind specifically to DNA single-strand breaks, enabling this
enzyme to catalyze the joining of nicks at salt concentrations that
inhibit other eukaryotic DNA ligases. However, deletion of this DNA
binding motif does not abolish either DNA joining activity or the
ability of this enzyme to complement the conditional lethal phenotype
of an Escherichia coli lig mutant, indicating that there are
other residues that interact with the nicked DNA substrate during the
ligation reaction. Using site-directed mutagenesis, we have identified
residues within the conserved peptide that play critical roles in the
interaction of DNA ligase III and presumably other eukaryotic DNA
ligases with nicked DNA during the latter stages of the DNA ligation reaction.
 |
EXPERIMENTAL PROCEDURES |
Plasmids--
Removal of a HindIII fragment
(nucleotides 21 to 697) of PARP cDNA, which encodes the two zinc
fingers of the human PARP (residues 1-234) from pTG PARP (11),
followed by religation, produced pTG PARP FI FII. cDNA
sequences encoding each of the zinc fingers were amplified by the
polymerase chain reaction (PCR) and then reintroduced into pTG PARP
FI FII to produce pTG PARP FI and pTG PARP FII, which encode
PARP proteins with deletions of zinc finger I and zinc finger II, respectively.
A 1095-bp PstI fragment of DNA ligase III cDNA, which
encodes residues 1-360 of DNA ligase III (7, 14), was subcloned into
the prokaryotic expression vector pTG 161 (15) to generate the plasmid
pTG N-ter Lig III (Fig. 1). After removal of the 3' overhangs, the same
fragment was subcloned into the mammalian expression vector pBC (16) so
that the DNA ligase III open reading frame was expressed as a
glutathione S-transferase fusion protein.
Plasmids encoding oligohistidine (His)-tagged versions of DNA ligase
III polypeptides were constructed as follows. For full-length DNA
ligase III with an N-terminal His tag, the DNA ligase III open
reading frame was amplified from the glutathione
S-transferase-DNA ligase III plasmid (17) by the PCR
using Pwo polymerase (Roche Molecular Biochemicals). The PCR
product was digested with BamHI and SalI and
subcloned into the same restriction sites of pQE32 (Qiagen) to generate
pHis Lig III (Fig. 1). For His-tagged versions of DNA ligase III
that lack the N-terminal zinc finger motif ( Zf), a 2.4-kilobase pair
ApaI/SalI fragment of DNA ligase III cDNA
encoding residues 49-862 was subcloned into pBluescript II KS. The
2.4-kilobase pair fragment was released from pBluescript II KS by
digestion with KpnI and SalI and subcloned into
pQE32 to generate the plasmid pHis ZfLig III (Fig. 1). Constructs encoding His-tagged Zf DNA ligase III fusion proteins with single amino acid changes in the conserved peptide were generated by replacing
the 600-bp EcoRI/SalI fragment from the wild type
DNA ligase III cDNA with mutated 600-bp
EcoRI/SalI fragments (Fig. 1).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 1.
Mammalian DNA ligases III
and III : Fragments of DNA ligase III
encoded by different expression vectors. Alignment of the amino
acid sequences of DNA ligase III (922 residues) and DNA ligase
III (862 residues). These forms of DNA ligase III are generated by
an alternative splicing mechanism involving the exons encoding the C
termini of these enzymes. The unique C terminus of DNA ligase III
(residues 844-922) is indicated by vertical
lines. The unique C terminus of DNA ligase III (residues
844-862) is indicated by horizontal lines. The
black boxes corresponding to residues 421-426
and 712-727 indicate the active site motif and conserved peptide,
respectively. These conserved regions flank the conserved catalytic
domain of human DNA ligases. The zinc finger of DNA ligase III
(residues 18-55) is indicated by the diagonal
lines. Regions of DNA ligase III that are encoded by the
indicated expression plasmids are shown. The fragment of DNA ligase III
(residues 701-862) containing the conserved peptide with amino acid
substitutions (asterisk) that was used to replace the wild
type sequence is shown.
|
|
Mutagenesis of DNA Ligase III cDNA--
PCR-based
mutagenesis (18) was performed using DNA ligase III cDNA (14) as
the template. Amplification was carried out in a 50-µl volume
containing 200 ng of plasmid DNA, 50 µM dNTPs, 200 nM primers, 1× Pfu buffer (Stratagene), and 2.5 units of Pfu DNA polymerase. An initial cycle of 94 °C
for 2 min, 56 °C for 1 min, and 72 °C for 45 s was
performed, followed by 19 cycles of 94 °C for 30 s, 56 °C
for 1 min, and 72 °C for 45 s. Primer N4.5-2
(5'-GAAATGAAGCGAGTCAC-3') was paired with the degenerate backward
primers to generate "left" mutated PCR fragment, and T3-1
(5'-GCTGGAGCTCCACCGCGGTGG-3') was paired with degenerate forward
primers to generate "right" mutated PCR fragment. After removing
free primers and dNTPs, equimolar amounts of left and right PCR
fragments were mixed, and amplification was performed using primers A
(5'-GACCTGGTGGTCCTT-3') and T3-1 in a 50-µl reaction containing 10 mM Tris-HCl (pH 8.3), 2.5 mM MgCl2,
75 mM KCl, 5 nM EDTA, 50 µM dNTP,
15 ng of template, and 2.5 units of Pfu DNA polymerase. The
mixture was heated at 94 °C for 1 min and then cooled down to
54 °C at 0.1 °C/s. After incubation at 54 °C for 1 min, the
primers (200 nM each) were added. Amplification was carried
out by 25 cycles of 94 °C for 30 s, 54 °C for 1 min, and 72 °C for 1 min followed by a 5-min incubation at 72 °C. The
mutated DNA fragments (~600 bp) were purified using a Qiagen kit as
suggested by the manufacturer and then digested with EcoRI
and XbaI. The EcoRI-XbaI fragment was
isolated from an agarose gel and cloned into pBluescript SK. 6-12
clones from each mutagenesis experiment were sequenced using ABI dye
terminator chemistry. Clones that contained the desired mutations were
sequenced further to verify that no additional undesired mutations had
been introduced and then subcloned into expression vectors as
described above.
Analysis of the DNA Ligase III Zinc Finger by Immunoblotting,
Southwestern Blotting, and DNase I Footprinting--
Crude extracts of
plasmid-containing TGE900 bacteria were prepared as described
previously (11). Briefly, cells from a 1.5-ml culture were collected by
centrifugation and resuspended in 100 µl of 25 mM
Tris-HCl (pH 8.0), 50 mM glucose, 10 mM EDTA,
and 100 µl of sample buffer (50 mM Tris-HCl (pH 6.8), 6 M urea, 6% 2-mercaptoethanol, 3% SDS, 0.003% bromphenol
blue). After sonication, bacterial proteins were separated by
electrophoresis through a 10% SDS-polyacrylamide gel (19) and then
either stained with Coomassie blue or transferred to a nitrocellulose
membrane (BAS 83; Schleicher & Schuell). Immunoblotting experiments
with rabbit antibodies against the human PARP zinc finger FI (20) or
zinc finger FII (21) were carried out as described previously (22).
For DNA binding and DNase I footprinting assays, the membranes were
washed for 30 min in 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, and 0.1% Nonidet P-40 at room temperature and
then preincubated for 10 min at 0 °C in binding buffer (20 mM Tris-HCl (pH 8.0), 0.1 M NaCl, 2 mM MgCl2, 2 mM dithiothreitol
(DTT), 0.1% Nonidet P-40). After incubation for 1 h with 20 ng of
a 32P-end-labeled 66-bp duplex DNA (either with or without
a single nick) in the DNA binding buffer (23), the membranes were
washed three times with binding buffer at 0 °C and then either were
dried and subjected to autoradiography to visualize the protein-DNA complexes or were autoradiographed wet for 1 h so that the
filter-bound protein-DNA complex could be excised and used for DNase I
footprinting assays as described previously (23).
Purification of DNA Ligase III from Baculovirus-infected
Sf9 Insect Cells--
A recombinant baculovirus encoding DNA
ligase III was constructed by using the pFastbac BEV system (Life
Technologies, Inc.). Sf9 insect cells (250 ml) were grown to a
density of 2.0 × 106 cells/ml and then infected with
the recombinant virus at a multiplicity of infection of 1. After
rotation at 150 rpm for 64 h at 28 °C, the cells were harvested
by centrifugation, flash-frozen in liquid nitrogen, and stored at
80 °C. The frozen pellet was thawed on ice and then resuspended in
200 ml of 50 mM Tris-HCl (pH 7.5), 75 mM NaCl,
0.1% Nonidet P-40, 1 mM EDTA, 0.5 mM DTT, 1 mM phenylmethanesulfonyl fluoride, 1 mM
benzamidine-HCl, 1 µg/ml leupeptin, 2 µg/ml aprotinin, and 1 µg/ml pepstatin. After 30 min on ice, the lysate was cleared by
centrifugation at 35,000 rpm for 30 min in a Beckman 45 Ti rotor at
4 °C. Proteins in the cleared lysate were precipitated with 70%
ammonium sulfate. After collection by centrifugation, the precipitate
was resuspended in and dialyzed against 50 mM Tris-HCl (pH
7.5), 75 mM NaCl, 10% glycerol, 1 mM EDTA, 0.5 mM DTT, 1 mM phenylmethanesulfonyl fluoride, 1 mM benzamidine-HCl. The dialysate was then fractionated by
P11 phosphocellulose (Whatman) chromatography. Eluted fractions were
assayed for protein by the method of Bradford (24) and for DNA ligase
by detecting formation of a labeled enzyme-adenylate intermediate (see
below). Active fractions were pooled and fractionated by FPLC Resource
S chromatography and then by gel filtration chromatography using a
Superdex 200 column (Amersham Pharmacia Biotech). The peak fractions
from the gel filtration column were then aliquoted, flash-frozen in
liquid nitrogen, and stored at 80 °C.
Purification of His-tagged DNA Ligase III --
The E. coli strain M15 was transformed with plasmids encoding His-tagged
versions of DNA ligase III . Cultures (1 liter) were grown at
37 °C in LB medium containing 100 µg/ml ampicillin and 50 µg/ml
kanamycin. When the culture reached an A600 of
0.6, isopropyl thiogalactoside was added to a final concentration of 1 mM, and incubation was continued for 6 h. Bacterial
cells were collected by centrifugation and then resuspended in 50 ml of
ice-cold 50 mM Tris-HCl (pH 7.5), 50 mM NaCl,
2% Nonidet P-40, 1 mM phenylmethanesulfonyl fluoride, 1 mM benzamidine-HCl, 10 mM 2-mercaptoethanol.
After sonication, the lysate was clarified by centrifugation at 35,000 rpm for 30 min at 4 °C in a Beckman 45Ti rotor. The cleared lysate was loaded onto a 35-ml P11 phosphocellulose column that had been pre-equilibrated with buffer A (50 mM Tris-HCl (pH 7.5),
10% glycerol, 50 mM NaCl, 10 mM
2-mercaptoethanol, 1 mM phenylmethanesulfonyl fluoride, 1 mM benzamidine-HCl). After washing with buffer A, bound
proteins were eluted stepwise with buffer A containing 0.2 M and then 0.5 M NaCl. Eluted fractions were
assayed for protein by the method of Bradford (24) and for DNA ligase
by detecting formation of a labeled enzyme-adenylate intermediate (see
below). Fractions containing DNA ligase III , which was present in
the 0.5 M eluate, were pooled. After the addition of
imidazole to a final concentration of 10 mM, the sample was
incubated by constant rotation at 4 °C for 3 h with nickel
beads (1 ml of beads per 10 mg of protein) that had been
pre-equilibrated with buffer A containing 0.5 M NaCl and 10 mM imidazole. The beads were collected by centrifugation
and then washed five times with 50 ml of buffer A containing 20 mM imidazole. Bound proteins were batch-eluted from the
beads with buffer A containing 250 mM imidazole and 50 mM EDTA. After dialysis against buffer A, the dialysate was
aliquoted, flash-frozen in liquid nitrogen, and stored at
80 °C.
Electrophoretic Mobility Shift Assay--
A 38-bp duplex
containing a single nick (25) was constructed by annealing
oligonucleotides and used as the substrate for electrophoretic mobility
shift assays. The 38-mer (8 pmol) was end-labeled with polynucleotide
kinase (New England Biolabs) and [ -32P]ATP (Amersham
Pharmacia Biotech) to a specific activity of 105 cpm/µg
and then annealed with two complementary oligonucleotides (8 pmol of
each) to generate a labeled 38-bp duplex with a single nick.
Radiolabeled nicked duplexes (3.2 ng) and DNA ligase III (0.5 µg)
were incubated on ice in 50 mM Tris-HCl, (pH 7.5), 1 mM DTT, 5% glycerol, 0.1 mM ZnCl2,
and 60 µg/ml bovine serum albumin with 32 ng of linearized
pBluescript and KCl concentrations ranging from 100 to 400 mM. Similar assays were carried out in the presence of 32, 96, and 320 ng of cold 38-bp duplex, either intact or with a single
nick, at 100 mM KCl. After 30 min, samples were loaded onto
nondenaturing 5% polyacrylamide gels that had been prerun at 100 V for
30 min at 4 °C. After electrophoresis at 150 V for 4-6 h at 4 °C
in 1× TBE, gels were dried, and labeled oligonucleotides were detected
by autoradiography. The inclusion of the linear pBluescript molecules
inhibited formation of large DNA-protein complexes, which failed to
enter the gel, by nonspecific DNA binding.
Ligation Assay--
A 38-bp oligonucleotide containing a single
nick was used as the substrate in DNA joining assays (25). The 5' end
of the 20-mer, which forms one of the nick termini, was end-labeled
with polynucleotide kinase (New England Biolabs) and
[ -32P]ATP (Amersham Pharmacia Biotech) to a specific
activity of 106 cpm/µg. Reaction mixtures (60 µl),
which contained 60 mM Tris-HCl (pH 8.0), 10 mM
MgCl2, 5 mM DTT, 1 mM ATP, 50 µg/ml bovine serum albumin, DNA substrate (60,000 cpm) and DNA
ligase, were incubated at 16 °C for 30 min. After the addition of 10 µl of formamide dye solution (Amersham Pharmacia Biotech), samples
were heated at 85 °C for 3 min. Aliquots (3 µl) were separated by
denaturing gel electrophoresis. After fixing and drying, the dried gel
was exposed to x-ray film. DNA joining was detected by conversion of
the labeled 20-mer to a labeled 38-mer and quantitated by
PhosphorImager (Molecular Dynamics, Inc., Sunnyvale, CA) analysis.
Complementation of the Temperature-sensitive Phenotype of an E. coli lig Mutant by Expression of DNA Ligase III
Polypeptides--
The E. coli strain AK76 lig
ts7 was transformed with DNA ligase III plasmids. Overnight cultures
of transformants, which were grown at 30 °C, were streaked onto LB
agar plates containing 50 µg/ml ampicillin and 40 µg/ml isopropyl
thiogalactoside. The plates were then incubated at either 30 or
40 °C for 24 h.
Formation of DNA Ligase-Adenylate--
Reaction mixtures
contained 60 mM Tris-HCl (pH 8.0), 10 mM
MgCl2, 5 mM DTT, 50 µg/ml bovine serum
albumin, DNA ligase III, and 0.5 µCi of [ -32P] ATP
(3000 Ci/mmol, Amersham Pharmacia Biotech). After incubation, reactions
were stopped by the addition of SDS sample buffer, heated at 90 °C
for 5 min, and then electrophoresed through an SDS-polyacrylamide gel.
Labeled polypeptides were detected in the dried gel by either autoradiography or PhosphorImager analysis.
Formation of DNA-Adenylate--
Reaction mixtures containing 60 mM MES-NaOH (pH 6.4), 10 mM MgCl2,
5 mM DTT, 50 µg/ml bovine serum albumin, 20 µCi of
[ -32P]ATP, and DNA ligase III protein were incubated
at 20 °C for 15 min. At this time, 5 µg of the unlabeled 38-bp
oligonucleotide containing a single nick was added, and the incubation
was continued at 20 or 37 °C. Aliquots (10 µl) were removed at
various times and added to 5 µl of formamide dye solution, heated to
80 °C for 2 min, and then electrophoresed through a denaturing 10%
polyacrylamide gel. Labeled oligonucleotides in the dried gel were
visualized by autoradiography.
 |
RESULTS |
The Putative Zinc Finger of DNA Ligase III Is Immunologically
Related to Zinc Finger 1 of PARP and Binds Specifically to DNA Single
Strand Breaks--
The N-terminal region of PARP contains two
homologous sequences that correspond to two zinc fingers, finger I
(residues 1-97) and finger II (residues 106-207), that are encoded by
the first four exons of the PARP gene (26). Analysis of the
open reading frame encoded by human DNA ligase III cDNA revealed
that this polypeptide has a putative zinc finger structure at its N
terminus (7) that exhibits homology with the PARP zinc fingers (Fig. 2A). A fragment of the DNA
ligase III cDNA open reading frame encompassing the putative zinc
finger of DNA ligase III (residues 1-360) was subcloned, and the
polypeptide was overexpressed in E. coli. This polypeptide
cross-reacted with an antibody that specifically recognizes finger I of
PARP but did not cross-react with an antibody that specifically
recognizes finger II of PARP (Fig. 2B). Thus, the putative
zinc finger of DNA ligase III is antigenically related to PARP finger
I.

View larger version (65K):
[in this window]
[in a new window]
|
Fig. 2.
Alignment of the amino acid sequences of
human PARP zinc finger domain FI and zinc finger domain FII with the
putative zinc finger of human DNA ligase III: Cross-reactivity of
antibodies specific for PARP FI and PARP FII with the putative zinc
finger of human DNA ligase III. A, the alignment of
PARP finger domain FI (residues 1-97), PARP finger domain FII
(residues 106-207), and the putative zinc finger of human DNA ligase
III (residues 1-97) is shown. Spaces (periods) have been
introduced to optimize the alignment. Identical amino acids or
conservative changes are in boldface uppercase
type. Unrelated amino acids are in normal
lowercase type. B, extracts of
E. coli cells overexpressing full-length PARP
(PARP) or PARP deletion mutants lacking zinc finger I
( FI), finger II ( FII), or both zinc fingers
( 2F) and the N-terminal 360 residues of DNA ligase III
(N-Lig III). Proteins were separated through
SDS-polyacrylamide gels and transferred to nitrocellulose membranes.
The membranes were incubated with polyclonal antibodies specific for
either PARP zinc finger domain I (anti FI antibody) or PARP
zinc finger domain II (anti F II antibody) as indicated. The
positions of molecular mass standards are shown on the
left.
|
|
A characteristic feature of the PARP zinc fingers is their ability to
bind to DNA breaks, in particular single strand breaks (11, 12). Like
PARP, the N-terminal fragment of DNA ligase III formed a specific
complex with a labeled, nicked DNA probe in Southwestern blotting
assays (Fig. 3A). Further
analysis of these DNA-protein complexes by DNase I footprinting
revealed that PARP and the N-terminal fragment of DNA ligase III bind
to a similar region of the DNA probe that encompasses the nick at
position 33 in probe 2 (Fig. 3B). To demonstrate that the
DNase I protection is caused by the DNA ligase III zinc finger binding
specifically to the nick, we have constructed DNA duplexes that either
lack a nick (probe 1) or contain a single nick at position 22 (probe 3). In these experiments, DNA ligase III purified from E. coli (Fig. 4A) was
immobilized on nitrocellulose and incubated with the DNA probes, and
the resultant DNA-protein complexes were treated with DNase I. The
pattern of the DNase I digestions from the DNA-protein complexes (Fig.
3D) was compared with the patterns generated by digestion of
the DNA substrates alone (Fig. 3C). As expected, no region
of protection was observed with the intact duplex, whereas a footprint
that was dependent upon the position of the nick was detected in assays
with the nicked DNA probes (Fig. 3D). These results
demonstrate that the N-terminal zinc finger of DNA ligase III binds to
DNA single strand breaks.

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 3.
Analysis of the DNA binding properties of the
DNA ligase III zinc finger by Southwestern blotting and DNase I
footprinting. Extracts were prepared from E. coli cells
overexpressing full-length PARP (pTG PARP) or the N-terminal
360 residues of DNA ligase III (pTG-Nter Lig III) and from
cells containing the empty expression vector (pTG). Proteins
were separated through SDS-polyacrylamide gels and transferred to
nitrocellulose membranes. A, the membrane was incubated with
the indicated 66-bp 32P-end-labeled probe 2 harboring a
nick at position 33 as described under "Experimental Procedures."
Labeled protein-DNA complexes were detected by autoradiography. The
positions of molecular mass standards are shown on the left.
B, the indicated labeled protein-DNA complexes were excised
from the SDS gel and incubated with DNase I as described under
"Experimental Procedures." The first lane
contains degradation products generated from labeled probe 2 by the
guanine-specific reaction. The protected region extending on either
side of the nick at position 33 is bracketed. C,
DNase I digestion products generated from the labeled probes 1, 2, and
3. D, DNA ligase III (1 µg) purified from E. coli was spotted onto the nitrocellulose membrane prior to
incubation with the indicated labeled probe. DNase I digestion products
from the labeled DNA-protein complexes are shown. The protected regions
extending on either side of the nicks at positions 23 and 33 are
bracketed.
|
|

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 4.
Size, immunoreactivity, and activity of
purified DNA ligase III polypeptides.
Untagged full-length DNA ligase III (Lig III-BV),
His-tagged full-length DNA ligase III (Lig III-E), and
His-tagged DNA ligase III lacking the zinc finger (Lig
III- Zf) were purified as described under "Experimental
Procedures." A, DNA ligase III polypeptides (2.0 µg
of each) were separated by SDS-polyacrylamide gel electrophoresis and
then stained with Coomassie Blue. The positions of molecular mass
standards are shown on the left. B, after
separation by SDS-polyacrylamide gel electrophoresis, DNA ligase III
polypeptides (200 ng of each) were transferred to a nitrocellulose
membrane. The membrane was incubated with polyclonal antibodies
specific for PARP zinc finger domain I. Antigen-antibody complexes were
detected by enhanced chemiluminescence. C, DNA ligase III
polypeptides (200 ng of each) were incubated with
[ -32P]ATP as described under "Experimental
Procedures." After separation by SDS-polyacrylamide gel
electrophoresis, labeled polypeptides were detected by
autoradiography.
|
|
Effect of the DNA Ligase III Zinc Finger on DNA Binding and DNA
Joining in Vitro--
We have chosen to further examine the
biochemical properties of the DNA ligase III zinc finger in DNA ligase
III , since this form of the enzyme, which is generated by tissue and
cell type alternative splicing (17), is more amenable to overexpression and purification than the form and does not interact with Xrcc1 (17). Full length and zinc finger-deleted ( Zf) versions of DNA
ligase III , each with an N-terminal His tag, were purified to near
homogeneity from E. coli. (Fig. 4A). In addition,
untagged full-length DNA ligase III was purified to near homogeneity
from baculovirus-infected insect cells (Fig. 4A). As
expected, there was no significant difference in the ability of these
polypeptides to form a labeled enzyme-AMP complex (Fig. 4C),
and both full-length versions but not the zinc finger-deleted version
of DNA ligase III cross-reacted with the PARP finger I antibody
(Fig. 4B).
In electrophoretic mobility shift assays, full-length DNA ligase III
formed a stable complex with nicked duplex DNA from 100 to 400 mM KCl (Fig. 5A).
In contrast, complex formation by the Zf version of DNA ligase
III was not detectable under the same reaction conditions. The
labeled DNA substrate has two double strand ends in addition to the
internal nick. To examine the binding of the DNA ligase III zinc finger
to single and double strand interruptions, increasing amounts of
unlabeled versions of the substrate, either with or without a nick,
were added to the reactions (Fig. 5B). From this experiment,
it is apparent that the nicked duplex is a more effective inhibitor of
complex formation than the intact duplex. For example, labeled complex
formation was 60% inhibited by a 30-fold molar excess of unlabeled
nicked duplex, whereas labeled complex formation was only 30%
inhibited by the same molar excess of unlabeled intact duplex. These
results indicate that the zinc finger of DNA ligase III preferentially
binds to DNA single strand breaks.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 5.
Complex formation with and ligation of nicked
DNA by DNA ligase III with and without the
zinc finger: Influence of salt concentration. Untagged full-length
DNA ligase III (Lig III-BV, 0.5 µg), and His-tagged DNA
ligase III lacking the zinc finger (Lig III- Zf, 0.5 µg) were incubated with a labeled, nicked DNA substrate as described
under "Experimental Procedures." After separation by nondenaturing
gel electrophoresis, labeled oligonucleotides were detected by
autoradiography. , no enzyme. A, assays were carried out at
increasing KCl concentrations (100, 200, 300, and 400 mM)
as indicated. B, assays were carried out at 100 mM KCl with increasing amounts of cold duplex (32, 96, and
320 ng), either intact or nicked. The amounts of cold competitor
correspond to 10, 30, and 100 times the amount of labeled probe,
respectively. C, ligation of a labeled DNA substrate
containing a single nick was measured as described under
"Experimental Procedures." Assays, which contained 0.3 ng of each
DNA ligase, were carried out at increasing KCl concentrations.
Activities are expressed as a percentage of the highest activity for
each enzyme. Open triangles, His-tagged DNA
ligase III lacking the zinc finger; open
squares, untagged full-length DNA ligase III ;
open circles, untagged full-length DNA ligase
I.
|
|
To examine whether the DNA ligase III zinc finger influences the DNA
ligation reaction, the DNA joining activities of Zf and full-length
versions of DNA ligase III were compared (Fig. 5C). There
was no significant difference in their specific activities when
measured at the optimal monovalent ion concentration for each enzyme.
However, the DNA joining activity of full-length DNA ligase III
remained relatively constant from 50 to 200 mM KCl (Fig.
5C), whereas the Zf version of DNA ligase III retained only about 20% activity at 200 mM NaCl (Fig.
5C). This degree of inhibition was similar to that of DNA
ligase I (Fig. 5C), an enzyme that lacks an obvious DNA
binding motif and is probably tethered to DNA substrates in
vivo by binding to proliferating cell nuclear antigen (27).
Similar results were obtained with NaCl (data not shown). In summary,
these in vitro studies demonstrate that the zinc finger of
DNA ligase III is not required for DNA joining in vitro, but
it does enable this enzyme to bind to and ligate nicked DNA at
physiological salt concentrations.
Based on the results described above, we considered the possibility
that the DNA ligase III zinc finger may be required for in
vivo function. To test this, we compared the ability of DNA ligase
III , with and without the zinc finger, to complement the conditional
lethal phenotype of an E. coli lig mutant. Both full-length and zinc finger-deleted versions of DNA ligase III expressed as either
His-tagged or glutathione S-transferase fusion proteins enabled the E. coli strain to grow at the nonpermissive
temperature, whereas no growth was observed when the same strain was
transformed with the empty expression vectors. Thus, the DNA ligase III
zinc finger is not required for DNA joining in vivo, at
least in E. coli.
Identification of Amino Acids That Are Required for the Interaction
of DNA Ligase III with Nicks during the Ligation Reaction--
To
identify amino acids that are required for DNA joining, in particular
for transferring the AMP group from the DNA ligase to the 5'-phosphate
terminus of a nick and the subsequent formation of a phosphodiester
bond, we focused on the 16-amino acid sequence that is conserved within
the catalytic domain of eukaryotic DNA ligases and is referred to as
the conserved peptide (Fig.
6A). Notable features of the
conserved peptide include a sequence RFPR that is invariant among human
DNA ligases and a high proportion of basic amino acids. The C-terminal
10 residues of the conserved motif correspond to motif VI, which was
identified based on its conservation in DNA ligases and mRNA
capping enzymes (3). Single amino acid changes at positions throughout
the conserved peptide of DNA ligase III that are invariant or highly
conserved in human DNA ligases (Fig. 6B) were made in the
His-tagged Zf version of DNA ligase III to facilitate
purification and analysis of DNA interactions involving the catalytic
domain.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
Alignment of the conserved peptide sequences
of human DNA ligases I, III, and IV: Effect of amino acid substitutions
within the conserved peptide of DNA ligase III
on the ability of this enzyme to form the enzyme-AMP complex and
to complement an E. coli lig mutant.
A, alignment of the conserved peptides of human DNA ligases
I, III, and IV. Invariant residues are indicated in boldface
type. B, expression plasmids encoding versions of
DNA ligase III lacking the zinc finger and with the indicated amino
acid substitutions within the conserved peptide were constructed and
transformed into E. coli strains. The abilities of these
polypeptides to form a labeled enzyme-AMP complex and to enable an
E. coli lig mutant to grow at 42 °C, which were examined
as described under "Experimental Procedures," are shown.
|
|
Initially, the effects of amino acid changes on the ability of DNA
ligase III to complement the conditional lethal phenotype of an
E. coli lig mutant were examined. Replacement of glycine 712 with alanine and proline 718 with either alanine or threonine did not
abolish complementation activity (Fig. 6B). Thus, we
conclude that, although these residues are invariant within the
conserved peptide of eukaryotic DNA ligases, relatively conservative
substitutions do not abolish catalytic activity. Similar results were
obtained when arginine 722, a conserved basic amino acid residue within the conserved peptide, was replaced with either glutamine or valine (Fig. 6B).
DNA ligase III polypeptides encoded by plasmids that failed to
complement the temperature sensitivity of the E. coli lig strain were selected for further analysis. After partial purification by metal-chelating chromatography, the ability of the DNA ligase III
polypeptides to form the enzyme-AMP complex was examined. The
substitutions serine 714 with isoleucine, arginine 724 with glycine,
and lysine 727 with glycine all resulted in polypeptides that were
unable to form the covalent enzyme-AMP reaction intermediate (Fig.
6B). An example of one of these defective polypeptides, K727G, which has been purified to near homogeneity by phosphocellulose and metal-chelating chromatography, is shown in Fig.
7. The failure of these altered versions
of DNA ligase III to form a labeled enzyme-AMP complex was not due
to the presence of a high proportion of enzyme-AMP complexes in the
purified fraction because preincubation with pyrophosphate, which
reverses the first step of the ligation reaction, had no effect on
enzyme-AMP formation by these polypeptides (data not shown). Thus,
these amino acid changes result in polypeptides that are defective in
the first step of the ligation reaction.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 7.
Purification of DNA ligase
III polypeptides with amino acid substitutions
within the conserved peptide: Effect of the amino acid changes on
enzyme-AMP formation. His-tagged versions of DNA ligase III
lacking the zinc finger and with the indicated amino acid changes
within the conserved peptide were purified to near homogeneity as
described under "Experimental Procedures." A, after separation by
SDS-polyacrylamide gel electrophoresis, the polypeptides (2.0 µg of
each) were detected by staining with Coomassie Blue. B, the
same DNA ligase III polypeptides (5 pmol of each) were incubated
with [ -32P]ATP as described under "Experimental
Procedures." After separation by SDS-polyacrylamide gel
electrophoresis, labeled polypeptides were detected by autoradiography.
The positions of molecular mass standards are indicated on the
left. wt, wild type.
|
|
Another group of amino acid substitutions, arginine 716 with glycine,
phenylalanine 717 with leucine, and arginine 719 with glycine, resulted
in polypeptides that were not defective in enzyme-AMP formation but
still failed to complement the E. coli lig mutant (Fig.
6B). Formation of the enzyme-AMP complex by these
polypeptides and a polypeptide with the wild type sequence, which have
been purified to near homogeneity, is shown in Fig. 7. The lack of functional complementation does not appear to be due to differences in
expression levels or protein stability because these polypeptides were
expressed at similar levels to the wild type polypeptide and were
obtained in similar yields after purification by phosphocellulose and
metal-chelating chromatography (data not shown). Therefore, we examined
the ability of these enzymes to catalyze phosphodiester bond formation.
The DNA joining activities of the R716G and F717L polypeptides were
greater than 100-fold less than that of the wild type polypeptide (Fig.
8A). Surprisingly, the R719G
polypeptide had the same or even slightly higher DNA joining activity
than the polypeptide with the wild type sequence under these reaction conditions (Fig. 8A). Studies to investigate the paradoxical
in vivo (Fig. 6B) and in vitro (Fig.
8A) results obtained with the R719G polypeptide are
described later.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 8.
DNA joining and DNA-adenylate formation by
wild type (wt), R716G, F717L, and R719G DNA ligase
III polypeptides. A, DNA
joining assays were carried out at 16 °C for 15 min as described
under "Experimental Procedures." , no enzyme. Increasing amounts
(1, 2, 5, and 10 fmol of each) of His-tagged Zf DNA ligase III
polypeptides with the indicated amino acid substitutions were added to
the reactions. B, after the indicated His-tagged Zf DNA
ligase III polypeptides (5 pmol of each) were incubated with
[ -32P]ATP for 20 min at 20 °C to form the labeled
enzyme-adenylate intermediate, unlabeled nicked substrate (2 µg) was
added. Aliquots were removed after 10, 20, 30, and 40 s and added
to formamide dye solution to stop the reaction. Samples were
electrophoresed through a 10% denaturing polyacrylamide gel. Labeled
oligonucleotides were detected by autoradiography. The positions of the
DNA-AMP intermediate (18-mer plus AMP) and a labeled 18-mer
(lane c) are indicated on the
left.
|
|
The failure of the R716G and F717L polypeptides to catalyze
phosphodiester bond formation could be explained either by a defect in
one or both of the latter two steps of the ligation reaction, formation
of the DNA-AMP intermediate, and the subsequent phosphodiester bond
formation. To address this issue, labeled enzyme-AMP complexes were
incubated with an unlabeled duplex DNA containing a single nick.
Transfer of the labeled AMP moiety results in the formation of a
labeled AMP-DNA intermediate. The consumption of this intermediate in
the final step of the ligation reaction, phosphodiester formation, results in the release in the labeled AMP moiety from the
oligonucleotide. In reactions with the wild type polypeptide, the
expected initial accumulation and subsequent consumption of the
DNA-adenylate intermediate was observed (Fig. 8B). In
contrast, both the R716G and F717L polypeptides were severely impaired
in their ability to transfer the AMP moiety to the DNA substrate. Thus,
we conclude that arginine 716 and phenylalanine 717 play critical roles
in the transfer of the AMP group from the DNA ligase to the
5'-phosphate terminus at a nick in duplex DNA.
The R719G Version of DNA Ligase III Is a Thermolabile
Enzyme--
The apparently normal in vitro DNA joining
activity of the R719G polypeptide was unexpected because expression of
this polypeptide did not complement the temperature-sensitive phenotype
of the E. coli lig mutant. Since the ligation and
complementation assays were carried out at 16 and 42 °C,
respectively, we considered the possibility that the R719G enzyme is
heat-labile. Consistent with this idea, the R719G polypeptide had wild
type joining activity at both 16 °C (Fig. 8A) and
20 °C (data not shown) but was inactive at 37 °C (Fig.
9A). Next, we investigated the
effect of temperature on different stages of the ligation reaction.
Formation of the labeled enzyme-adenylate by R719G was reduced about
3-fold at 37 °C compared with 25 °C, whereas the activity of
comparable wild type polypeptide was only 1.4-fold lower at the higher
temperature (data not shown). Since the adenylylation reaction is rapid
(4), it is possible that adenylylation occurs prior to thermal
inactivation. At 25 °C, enzyme-adenylate formation by both R719G and
wild type polypeptides reached a maximum within the first 30 s of
incubation (Fig. 9B). When these polypeptides were
preincubated at 37 °C prior to incubation at 25 °C, the rate of
enzyme-adenylate formation was reduced. Although the R719G polypeptide
was more severely affected than the wild type polypeptide, the
difference was only 2-3-fold (Fig. 9B). These results
suggest that the R719G DNA ligase is more severely impaired in the
latter steps of the DNA ligation reaction at higher temperatures.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 9.
Temperature dependence of the catalytic
activities of wild type (wt) and R719G DNA ligase
III polypeptides. A, DNA
joining assays were carried out at 37 °C for 15 min as described
under "Experimental Procedures." , no enzyme. Increasing amounts
(1, 2, 5, and 10 fmol of each) of wild type and R719G versions of
His-tagged Zf DNA ligase III polypeptides were added to the
reactions. B, wild type and R719G versions of His-tagged
Zf DNA ligase III polypeptides (1 pmol of each) were preincubated
at either 25 °C (top panel) or 37 °C
(bottom panel) for 5 min prior to the addition of
[ -32P]ATP. Incubation was then continued at 25 °C,
and aliquots were removed after 0.5, 1, 2, and 5 min. Samples were
separated by SDS-polyacrylamide gel electrophoresis, and the formation
of a labeled 97-kDa enzyme-AMP complex was detected by autoradiography.
C, after the wild type and R719G versions of His-tagged
Zf DNA ligase III polypeptides (5 pmol of each) were incubated
with [ -32P]ATP for 20 min at 20 °C to form the
labeled enzyme-adenylate intermediate, unlabeled nicked substrate (5 µg) was added. Incubation was continued at either 20 or 37 °C as
indicated. Aliquots were removed after 10, 20, 30, and 40 s and
added to formamide dye solution to stop the reaction. D, the
labeled wild type and R719G enzyme-adenylate intermediates were
preincubated for 5 min at 37 °C prior to the addition of the
unlabeled nicked substrate and incubation at 20 °C. Aliquots were
removed after 10, 20, 30, and 40 s and added to formamide dye
solution to stop the reaction. Samples were electrophoresed through a
10% denaturing polyacrylamide gel. Labeled oligonucleotides were
detected by autoradiography. The positions of the DNA-AMP intermediate
(18-mer plus AMP) and a labeled 18-mer (lane c)
are indicated on the left.
|
|
To confirm this, the labeled enzyme intermediate was formed at 20 °C
and then incubated with an unlabeled DNA substrate containing a nick.
Formation of a labeled DNA adenylate and the subsequent consumption of
this reaction intermediate in the last step of the ligation reaction
was monitored as a function of time at both 20 and 37 °C. With the
wild type enzyme, the accumulation and decline of the DNA adenylate
intermediate was observed at both temperatures (Fig. 9C). A
similar profile was observed with R719G at 20 °C, but no significant
formation of the DNA adenylate was detected at 37 °C (Fig.
9C). Thus, we conclude that the R719G polypeptide is a
heat-labile enzyme that is unable to transfer the AMP moiety from
itself to the 5'-phosphate terminus of a nick in DNA at the
nonpermissive temperature. Interestingly, thermal inactivation of R719G
DNA ligase activity is reversible. Formation of the DNA adenylate
intermediate was observed after the labeled enzyme-adenylate
intermediate was preincubated at 37 °C prior to incubation with the
nicked DNA substrate at 20 °C (Fig. 9D).
 |
DISCUSSION |
Three mammalian genes encoding DNA ligases have been identified
(1, 2). Although these enzymes have distinct cellular functions, they
utilize the same basic reaction mechanism. Thus, it seems reasonable to
assume that once recruited to sites of discontinuity in the
phosphodiester backbone, the same key residues within the conserved
catalytic domain of these enzymes will mediate transfer of the AMP
group from the DNA ligase to the DNA substrate followed by
phosphodiester bond formation. In this study, we have investigated the
role of amino acids within the conserved peptide motif (which includes
motif VI), a 16-amino acid sequence that was originally identified in
vaccinia DNA ligase (1-3, 5). Amino acid substitutions at three
residues, serine 714, arginine 724, and lysine 727, within the
conserved peptide of DNA ligase III abolished enzyme-AMP formation.
The positively charged residues correspond to arginine 295 and lysine
298 within motif VI of Chlorella virus mRNA capping enzyme, which
is also a nucleotidyl transferase (28). In the closed conformation of
the mRNA capping enzyme, these residues appear to contact the
triphosphate tail of the GTP (29). Thus, the inability of the mutant
DNA ligases to form an enzyme-AMP complex supports the notion that
these residues play a critical role in positioning the nucleoside
triphosphate for attack by the nucleophilic lysine (residue 421 in DNA
ligase III) in nucleotidyl transferases (29).
The sequence RFPR is invariant within the conserved peptide of human
DNA ligases (1, 2). None of these residues was required for enzyme-AMP
formation, but replacement of either the first arginine with glycine or
the adjacent phenylanine residue with leucine resulted in polypeptides
that were defective in transferring the AMP moiety to the DNA
substrate. Furthermore, substitution of the second arginine residue
with a glycine residue generated a temperature-sensitive enzyme that
was more severely deficient in the nucleotidyl transfer reaction
compared with formation of the enzyme-AMP complex. In the crystal
structures of the mRNA capping enzyme and T7 DNA ligase (10, 29),
the region containing the conserved peptide is relatively unstructured
and undergoes a large conformational change between the open and closed
forms of the mRNA capping enzyme. Since the thermal inactivation of R719G is reversible, it seems likely that the denaturation at elevated
temperatures is localized to a small region encompassing the conserved
peptide. Together with the structural studies (10, 29), our enzymatic
results suggest that the RFPR motif binds to and positions the nicked
DNA substrate for the nucleotidyl transfer reaction that presumably
occurs within the closed conformation of the enzyme.
The cellular functions of the mammalian DNA ligases appear to be
determined by their recruitment to specific DNA substrates in
vivo (1, 2). The binding to different protein partners via the
unique amino acid sequences that flank the catalytic domain of these
enzymes is one mechanism by which this functional specificity is
mediated. For example, the partner of DNA ligase IV, XRCC4 interacts
with the heterodimeric complex, Ku, that binds to DNA double strand
breaks (30-32), whereas DNA ligase I is tethered to DNA molecules via
an interaction with the clamp protein, proliferating cell nuclear
antigen (27). DNA ligase III and are distinct from all other DNA
ligases identified to date in that they have a zinc finger motif that
binds to DNA (7, 17). Interestingly, this zinc finger, which is located
at the N terminus of DNA ligase III, is homologous with the two
N-terminal zinc fingers of PARP that bind to DNA strand breaks and
activate the polymerase activity (7, 11, 12). Since PARP finger II
plays a critical role in the interaction with DNA single strand breaks
(11, 12), it was proposed that the zinc finger of DNA ligase III would
resemble PARP finger II and would act as a molecular nick sensor (13). In this study, we demonstrate that the DNA ligase III zinc finger is in
fact most closely related to PARP finger I. However, the DNA ligase III
zinc finger does form a specific complex with a nick in duplex DNA as
determined by DNase I footprinting. Furthermore, the DNA ligase III
zinc finger allows this enzyme to form a stable complex with and join
nicked DNA at physiological salt concentrations.
In this study, expression of zinc finger-deleted versions of DNA ligase
III complemented the conditional lethal phenotype of E. coli
lig mutants. Furthermore, vaccinia DNA ligase, which exhibits
homology with DNA ligase III over its entire length but lacks an
N-terminal zinc finger (5, 7, 14), corrects the temperature-sensitive
phenotype of an S. cerevisiae cdc9 DNA ligase mutant (33).
Thus, the zinc finger is not required for in vivo function
in heterologous organisms. Interestingly, the genes encoding PARP, DNA
ligase III, and XRCC1 appear to be restricted to multicellular organisms. Furthermore, the sensitivity of cell lines deficient in
either PARP or the DNA ligase III -XRCC1 complex to alkylating agents
and ionizing radiation is consistent with these enzymes acting in the
same DNA repair pathways (34-36). In support of this idea, XRCC1
interacts via different regions with PARP, DNA ligase III , and also
DNA polymerase , suggesting that these proteins may function
together as a multiprotein repair complex (17, 37-39). Although the
functions of the similar DNA binding domains of PARP and DNA ligase
III in the repair reaction mediated by this multiprotein complex
have not been defined, there is evidence indicating that the DNA
binding properties of the two zinc finger DNA binding domains of PARP
are different from those of the DNA ligase III zinc finger.
Overexpression of the PARP DNA binding domain has a dominant negative
effect on cellular responses to DNA damage (40), whereas overexpression
of the DNA ligase III zinc finger does not inhibit activation of
poly(ADP-ribosylation) by PARP after DNA damage by hydrogen peroxide
(data not shown). One interpretation of this observation is that the
PARP DNA binding domain binds to DNA strand breaks with higher affinity
and stability than the DNA ligase III zinc finger. This suggests that
PARP acts as the sensor of genomic DNA single strand breaks and that
the binding of PARP to a single strand break results in the recruitment of the XRCC1-DNA ligase III complex and other repair proteins. A
possible role for the DNA ligase III zinc finger in this repair pathway
would be to displace the DNA binding domain of automodified PARP, which
binds less tightly to nicked DNA, from the single strand break,
allowing the DNA ligase and other repair proteins access to the DNA lesion.
In summary, we have identified two functionally distinct regions within
mammalian DNA ligase III that interact with nicked DNA. The sequence
RFPR, which is present within the catalytic domain, is required for the
transfer of the AMP group from the enzyme to the 5'-phosphate terminus
at a DNA nick. Since this sequence motif is invariant in mammalian DNA
ligases, it is likely to fulfill the same role in the ligation reaction
catalyzed by DNA ligases I and IV. In contrast, the zinc finger motif
is a unique feature that distinguishes DNA ligase III from other DNA ligases. The DNA ligase III zinc finger targets this enzyme to nicks in
duplex DNA, enabling it to form stable complexes with and ligate nicked
DNA at physiological salt concentrations in vitro. Further
studies will provide insights into the in vivo role of this
DNA binding activity in base excision and single strand break repair pathways.
 |
ACKNOWLEDGEMENTS |
We thank Sylviane Muller for the gift of PARP
antibodies. We are grateful to the DNA Sequencing Core Facility at
Glaxo Wellcome for sequencing all of the samples generated by
site-directed mutagenesis.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grant GM47251 (to A. E. T.), by L'Association pour la
Recherche Contre le Cancer, by Electricité de France, by CNRS
Grant ACC-SV Radiations ionizantes, and by the Commissariat à
l'Energie Atomique.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
A UNCF-MERCK fellow.
**
To whom correspondence should be addressed: Dept. of Molecular
Medicine, Institute of Biotechnology, The University of Texas Health
Science Center at San Antonio, 15355 Lambda Dr., San Antonio, TX 78245. Tel.: 210-567-7327; Fax: 210-567-7324; E-mail:
tomkinson@uthscsa.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
PARP, poly(ADP-ribose) polymerase;
DTT, dithiothreitol;
MES, 2-(N-morpholino)ethanesulfonic acid;
PCR, polymerase chain
reaction;
Zf, zinc finger-deleted;
bp, base pair(s)..
 |
REFERENCES |
| 1.
|
Tomkinson, A. E.,
and Levin, D. S.
(1997)
BioEssays
19,
893-901[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Tomkinson, A. E.,
and Mackey, Z. B.
(1998)
Mutat. Res.
407,
1-9[Medline]
[Order article via Infotrieve]
|
| 3.
|
Shuman, S.,
and Schwer, B.
(1995)
Mol. Microbiol.
17,
405-410[Medline]
[Order article via Infotrieve]
|
| 4.
|
Tomkinson, A. E.,
Totty, N. F.,
Ginsburg, M.,
and Lindahl, T.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
400-404[Abstract/Free Full Text]
|
| 5.
|
Smith, G. L.,
Chan, Y. S.,
and Kerr, S. M.
(1989)
Nucleic Acids Res.
17,
9051-9062[Abstract/Free Full Text]
|
| 6.
|
Hammond, J. M.,
Kerr, S. M.,
Smith, G. L.,
and Dixon, L. K.
(1992)
Nucleic Acids Res.
20,
2667-2671[Abstract/Free Full Text]
|
| 7.
|
Wei, Y.-F.,
Robins, P.,
Carter, K.,
Caldecott, K.,
Pappin, D. J. C., Yu, G.-L.,
Wang, R.-P.,
Shell, B. K.,
Nash, R. A.,
Schar, P.,
Barnes, D. E.,
Haseltine, W. A.,
and Lindahl, T.
(1995)
Mol. Cell. Biol.
15,
3206-3216[Abstract]
|
| 8.
|
Tomkinson, A. E.,
Lasko, D. D.,
Daly, G.,
and Lindahl, T.
(1990)
J. Biol. Chem.
265,
12611-12617[Abstract/Free Full Text]
|
| 9.
|
Barnes, D. E.,
Johnston, L. H.,
Kodama, K.,
Tomkinson, A. E.,
Lasko, D. D.,
and Lindahl, T.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
6679-6683[Abstract/Free Full Text]
|
| 10.
|
Subramanya, H. S.,
Doherty, A. J.,
Ashford, S. R.,
and Wigley, D. B.
(1996)
Cell
85,
607-615[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Gradwohl, G.,
Ménissier-de Murcia, J.,
Molinete, M.,
Simonin, F.,
Koken, M.,
Hoeijmakers, J. H. J.,
and de Murcia, G.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
2990-2994[Abstract/Free Full Text]
|
| 12.
|
Ikejima, M.,
Noguchi, S.,
Yamashita, R.,
Ogura, T.,
Sugimura, T.,
Gill, D. M.,
and Miwa, M.
(1990)
J. Biol. Chem.
265,
21907-21913[Abstract/Free Full Text]
|
| 13.
|
Caldecott, K. W.,
Aoufouchi, S.,
Johnson, P.,
and Shall, S.
(1996)
Nucleic Acids Res.
24,
4387-4394[Abstract/Free Full Text]
|
| 14.
|
Chen, J.,
Tomkinson, A. E.,
Ramos, W.,
Mackey, Z. B.,
Danehower, S.,
Walter, C. A.,
Schultz, R. A.,
Besterman, J. M.,
and Husain, I.
(1995)
Mol. Cell Biol.
15,
5412-5422[Abstract]
|
| 15.
|
Courtney, M.,
Buchwalder, A.,
Tessier, L. H.,
Jaye, M.,
Benavente, A.,
Balland, A.,
Kohli, V.,
Lathe, R.,
Tolstoshev, P.,
and Lecocq, J. P.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
669-673[Abstract/Free Full Text]
|
| 16.
|
Chatton, B.,
Bahr, A.,
Acker, J.,
and Kedinger, D.
(1995)
BioTechniques
18,
142-145[Medline]
[Order article via Infotrieve]
|
| 17.
|
Mackey, Z. B.,
Ramos, W.,
Levin, D. S.,
Walter, C. A.,
McCarrey, J. R.,
and Tomkinson, A. E.
(1996)
Mol. Cell Biol.
17,
989-998[Abstract]
|
| 18.
|
Higuchi, R.
(1990)
in
Recombinant PCR in PCR Protocols: A Guide to Methods and Applications
(Innis, M. A.
, Gelfand, D. H.
, Sninsky, J. J.
, and White, T. J., eds)
, pp. 177-183, Academic Press, Inc., New York
|
| 19.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Decker, P.,
Briand, J. P.,
de Murcia, G.,
Pero, R. W.,
Isenberg, D. A.,
and Muller, S.
(1998)
Arthritis Rheum.
41,
918-926[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Simonin, F.,
Briand, J. P.,
Muller, S.,
and de Murcia, G.
(1991)
Anal. Biochem.
195,
226-231[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Mazen, A.,
Ménissier-de Murcia, J.,
Molinete, M.,
Simonin, F.,
Gradwohl, G.,
Poirier, G.,
and de Murcia, G.
(1989)
Nucleic Acids Res.
17,
4689-4698[Abstract/Free Full Text]
|
| 23.
|
Ménissier-de Murcia, J.,
Molinete, M.,
Gradwohl, G.,
Simonin, F.,
and de Murcia, G.
(1989)
J. Mol. Biol.
210,
229-233[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Tomkinson, A. E.,
Tappe, N. J.,
and Friedberg, E. C.
(1992)
Biochemistry
31,
11762-11771[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Auer, B.,
Nagl, U.,
Herzog, H.,
Schneider, R.,
and Schweiger, M.
(1989)
DNA
8,
575-580[Medline]
[Order article via Infotrieve]
|
| 27.
|
Levin, D. S.,
Bai, W.,
and Tomkinson, A. E.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
12863-12868[Abstract/Free Full Text]
|
| 28.
|
Ho, C. K.,
van Etten, J. L.,
and Shuman, S.
(1996)
J. Virol.
70,
6658-6664[Abstract/Free Full Text]
|
| 29.
|
Hakansson, K.,
Doherty, A. J.,
Shuman, S.,
and Wigley, D. B.
(1997)
Cell
89,
545-553[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Critchlow, S. E.,
Bowater, R. P.,
and Jackson, S. P.
(1997)
Curr. Biol.
7,
588-598[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Grawunder, U.,
Wilm, M.,
Wu, X.,
Kulesza, P.,
Wilson, T. E.,
Mann, M.,
and Lieber, M. R.
(1997)
Nature
388,
492-495[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Leber, R.,
Wise, T. W.,
Mizuta, R.,
and Meek, K.
(1998)
J. Biol. Chem.
273,
1794-1801[Abstract/Free Full Text]
|
| 33.
|
Kerr, S. M.,
Johnston, L. H.,
Odell, M.,
Duncan, S. A.,
Law, K. M.,
and Smith, G. L.
(1991)
EMBO J.
10,
4343-4350[Medline]
[Order article via Infotrieve]
|
| 34.
|
Ménissier-de Murcia, J.,
Niedergang, C.,
Trucco, C.,
Ricoul, M.,
Ditrillaux, M., M.,
Olivier, F. J.,
Masson, M.,
Dierich, A.,
LeMeur, M.,
Wlatzinger, C.,
Chambon, P.,
and de Murcia, G.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
7303-7307[Abstract/Free Full Text]
|
| 35.
|
Thompson, L. H.,
Brookman, K. W.,
Jones, N. J.,
Allen, S. A.,
and Carrano, A. V.
(1990)
Mol. Cell. Biol.
10,
6160-6171[Abstract/Free Full Text]
|
| 36.
|
Caldecott, K. W.,
McKeown, C. K.,
Tucker, J. D.,
Stanker, L.,
and Thompson, L. H.
(1996)
Nucleic Acids Res.
23,
4836-4843[Abstract/Free Full Text]
|
| 37.
|
Masson, M.,
Niedergang, C.,
Schreiebr, V.,
Muller, S.,
Ménissier-de Murcia, J.,
and de Murcia, G.
(1998)
Mol. Cell. Biol.
18,
3563-3571[Abstract/Free Full Text]
|
| 38.
|
Kubota, Y.,
Nah, R. A.,
Klungland, A.,
Schar, P.,
Barnes, D. E.,
and Lindahl, T.
(1996)
EMBO J.
15,
6662-6670[Medline]
[Order article via Infotrieve]
|
| 39.
|
Nash, R. A.,
Caldecott, K.,
Barnes, D. E.,
and Lindahl, T.
(1997)
Biochemistry
36,
5207-5211[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Molinete, M.,
Vermeulen, W.,
Burkle, A.,
Ménissier-de Murcia, J.,
Kupper, J. H.,
Hoeijmakers, J. H. J,
and de Murcia, G.
(1993)
EMBO J.
12,
2109-2117[Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
U. Rass, I. Ahel, and S. C. West
Molecular Mechanism of DNA Deadenylation by the Neurological Disease Protein Aprataxin
J. Biol. Chem.,
December 5, 2008;
283(49):
33994 - 34001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Liang, L. Deng, S. C. Nguyen, X. Zhao, C. D. Maulion, C. Shao, and J. A. Tischfield
Human DNA ligases I and III, but not ligase IV, are required for microhomology-mediated end joining of DNA double-strand breaks
Nucleic Acids Res.,
June 1, 2008;
36(10):
3297 - 3310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cotner-Gohara, I.-K. Kim, A. E. Tomkinson, and T. Ellenberger
Two DNA-binding and Nick Recognition Modules in Human DNA Ligase III
J. Biol. Chem.,
April 18, 2008;
283(16):
10764 - 10772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Rosidi, M. Wang, W. Wu, A. Sharma, H. Wang, and G. Iliakis
Histone H1 functions as a stimulatory factor in backup pathways of NHEJ
Nucleic Acids Res.,
March 1, 2008;
36(5):
1610 - 1623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Mortusewicz, J.-C. Ame, V. Schreiber, and H. Leonhardt
Feedback-regulated poly(ADP-ribosyl)ation by PARP-1 is required for rapid response to DNA damage in living cells
Nucleic Acids Res.,
December 3, 2007;
35(22):
7665 - 7675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Dong and A. E. Tomkinson
ATM mediates oxidative stress-induced dephosphorylation of DNA ligase III{alpha}
Nucleic Acids Res.,
November 6, 2006;
34(20):
5721 - 5279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Mortusewicz, U. Rothbauer, M. C. Cardoso, and H. Leonhardt
Differential recruitment of DNA Ligase I and III to DNA repair sites
Nucleic Acids Res.,
July 19, 2006;
34(12):
3523 - 3532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Puebla-Osorio, D. B. Lacey, F. W. Alt, and C. Zhu
Early Embryonic Lethality Due to Targeted Inactivation of DNA Ligase III
Mol. Cell. Biol.,
May 15, 2006;
26(10):
3935 - 3941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Mortusewicz, L. Schermelleh, J. Walter, M. C. Cardoso, and H. Leonhardt
Recruitment of DNA methyltransferase I to DNA repair sites
PNAS,
June 21, 2005;
102(25):
8905 - 8909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, B. Rosidi, R. Perrault, M. Wang, L. Zhang, F. Windhofer, and G. Iliakis
DNA Ligase III as a Candidate Component of Backup Pathways of Nonhomologous End Joining
Cancer Res.,
May 15, 2005;
65(10):
4020 - 4030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Petrucco
Sensing DNA damage by PARP-like fingers
Nucleic Acids Res.,
December 1, 2003;
31(23):
6689 - 6699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Leppard, Z. Dong, Z. B. Mackey, and A. E. Tomkinson
Physical and Functional Interaction between DNA Ligase III{alpha} and Poly(ADP-Ribose) Polymerase 1 in DNA Single-Strand Break Repair
Mol. Cell. Biol.,
August 15, 2003;
23(16):
5919 - 5927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Petrucco, G. Volpi, A. Bolchi, C. Rivetti, and S. Ottonello
A Nick-sensing DNA 3'-Repair Enzyme from Arabidopsis
J. Biol. Chem.,
June 21, 2002;
277(26):
23675 - 23683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Sriskanda and S. Shuman
Conserved Residues in Domain Ia Are Required for the Reaction of Escherichia coli DNA Ligase with NAD+
J. Biol. Chem.,
March 15, 2002;
277(12):
9695 - 9700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Doherty and S. W. Suh
Structural and mechanistic conservation in DNA ligases
Nucleic Acids Res.,
November 1, 2000;
28(21):
4051 - 4058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Sriskanda, Z. Kelman, J. Hurwitz, and S. Shuman
Characterization of an ATP-dependent DNA ligase from the thermophilic archaeon Methanobacterium thermoautotrophicum
Nucleic Acids Res.,
June 1, 2000;
28(11):
2221 - 2228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Lindahl and R. D. Wood
Quality Control by DNA Repair
Science,
December 3, 1999;
286(5446):
1897 - 1905.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Chen, K. Trujillo, P. Sung, and A. E. Tomkinson
Interactions of the DNA Ligase IV-XRCC4 Complex with DNA Ends and the DNA-dependent Protein Kinase
J. Biol. Chem.,
August 18, 2000;
275(34):
26196 - 26205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Oei and M. Ziegler
ATP for the DNA Ligation Step in Base Excision Repair Is Generated from Poly(ADP-ribose)
J. Biol. Chem.,
July 21, 2000;
275(30):
23234 - 23239.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|